Diabetes News Archive
Recommendations for the management of type 2 diabetes have been updated, according to a consensus report by the American Diabetes Association and the European Association for the Study of Diabetes.
The risk for late-onset epilepsy was lower in patients with higher physical activity levels and moderate alcohol intake.
Day-and-night hybrid closed-loop insulin delivery improves glucose control compared with sensor-augmented pump therapy.
Approximately 28% of stroke patients have diabetes, and the presence of diabetes can increase the risk for poor stroke outcome.
Continuous positive airway pressure for obstructive sleep apnea in patients with type 2 diabetes offered no improvement in visual acuity compared with usual care alone.
A combined immunosuppressive regimen was found to be a highly effective and safe treatment for patients with type B insulin resistance.
But weight loss no different for online, in-person DPP for obese/overweight veterans with prediabetes.
Prevalence of diagnosed and undiagnosed diabetes 9.7 and 4.3%; prevalence increased with age.
SGLT-2i exhibited superior effects in terms of weight loss and did not increase the risk for hypoglycemia in dual therapy with sulfonylurea.
Repeated exposure to high levels of HbA1c was associated with increased risk for dementia in a cohort of patients age ≥50 with type 1 diabetes.
Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.
Racial/ethnic differences seen in the association of aldosterone with incident type 2 diabetes.
Researchers found that patients with T1DM and poor glycemic control were more frequently diagnosed with infections.
Excess risk differed by up to 5 times across different diagnosis age groups.
The infection developed within several months of the patients starting SGLT2 therapy and the drug was discontinued in most cases. All patients required surgery and there was 1 reported death.
The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.
The PedsQL 3.2 can assist in identify new and existing therapeutic interventions for individuals with different diabetes-specific health-related quality of life profiles.
Fills for insulin and newer medications increased by 40 and 39%, respectively.
Prevalences of diabetes and prediabetes higher among racial/ethnic minorities with mental illness.
Investigators sought to determine the safety and efficacy of electroacupuncture for painful diabetic peripheral neuropathy.
Physicians can stress the factors in a patient's control and change messaging about the condition.
The FDA has set a Prescription Drug User Fee Act target date of April 1, 2019.
The early diagnosis and management of prediabetes will have a significant impact on patient outcomes and healthcare spending.
Investigators compared low-carbohydrate with low-fat diet on glucose control and other metabolic and anthropometric variables in T2D.
Circulating hepatic markers may predict the risk for diabetes in women.
The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.
This represents the prospective study confirming an independent relationship between cardiovascular mortality and oxidative DNA damage in type 2 diabetes.
Compared with human neutral protamine Hagedorn insulin, basal insulin analogs do not reduce risk of hypoglycemia-linked ED visits or hospital admissions in T2D.
Small changes in health behaviors seen for partners of those newly diagnosed with diabetes.
Effectiveness of care and healthcare resource use for diabetes or cardiovascular disease were comparable among patients receiving care from an NP vs those managed by a PA.
The relationship between bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Patients with type 2 diabetes who were initially treated with multiple daily injections were assessed before and after switching to continuous subcutaneous insulin infusion.
Increased spending per encounter has been the biggest driver of overall rise in spending.
Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.
Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.
Investigators analyzed real world data to examine the risk for below-knee amputations in patients with type 2 diabetes taking canagliflozin vs other medications.
Investigators examined the relationship between the use of β-blockers and incidence of hypoglycemia and risk for mortality in hospitalized patients with diabetes.
Investigators compared 2 methods of delivering bolus insulin, pen vs patch, using metrics from continuous glucose monitoring.
Investigators examined the efficacy of liraglutide for the prevention of dementia in elderly patients with type 2 diabetes.
Investigators examined the effectiveness of oral agents vs insulin as an initial treatment option for people newly diagnosed with type 2 diabetes.
Investigators examined cardiovascular outcomes in patients with elevated triglyceridemia and diabetes treated with statins.
In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.
Investigators examined the incidence and outcomes of pneumonia in patients with acute ischemic stroke and type 2 diabetes.
The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.
MEDI0382 reduced body weight and normalized fasting and postprandial blood glucose levels in patients with type 2 diabetes.
Investigators examined the prevalence of chronic kidney disease in adults with type 1 diabetes compared with type 2 diabetes.
The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.
Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis.
Six of 18 systems met predetermined accuracy standard in three of three studies
Sodium chloride content of intravenous fluids does not affect neurologic events in children with diabetic ketoacidosis.
Deficits similar for long-term type 1 diabetes and age-matched patients with type 2 diabetes
Increased risk of subsequent diabetes independent of traditional diabetes risk factors
Much steeper decline in adjusted mean eGFR for those with diagnosed diabetes versus those without
The American Diabetes Association (ADA) has released a public policy statement that outlines long- and short-term recommendations for improving insulin affordability.
Per-person diabetes-attributable costs ranged from 374 in New Mexico to 1,610 in Washington, D.C.
For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists significantly reduce mortality rates compared with dipeptidyl peptidase 4 inhibitors.
The CDC conducted a study to estimate the prevalence of diagnosed diabetes among adults in 2016 by primary type.
Artificial intelligence software that can detect diabetic retinopathy has been approved by the U.S. Food and Drug Administration.
Benefits seen in markers of cardiometabolic disease, including insulin sensitivity
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
A diabetes transition registry may help adolescents with type 1 diabetes plan and prepare for independent adult care.
Better glycemic control, weight reduction with surgical treatment for youths with T2D, severe obesity
For adolescents with type 2 diabetes and severe obesity, surgical therapy facilitates glycemic control and weight reduction better than medical therapy.
A high fiber diet promotes gut bacteria that helps blood glucose control in patients with type 2 diabetes.
The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.
HbA1C, diabetes status, and cognitive decline during a span of 10 years were compared using data from the English Longitudinal Study of Ageing.
The ADA's updates include a modified patient-focused care algorithm as well as improved risk management for CVD.
The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers.
The new FDA approved short-acting insulin drug can be used to treat T1 and T2 diabetes.
With the help of a doctor and a weight loss plan, new research suggests type 2 diabetes can be reversed in less than a year.
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
With a little creativity, children with diabetes can enjoy the festivities of Halloween.
Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose.
After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.
The 12-year results show that Roux-en-Y gastric bypass offered long-term durability of weight loss and was associated with fewer obesity-related coexisting conditions compared with those who did not have the surgery.
The statement includes advances in care since the ADA's last position statement was published in 2003.
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
Consumption of alcohol 3 to 4 days weekly is associated with a significantly lower risk for diabetes in men and women.
Lifestyle interventions reduce gestational weight gain across various subgroups of women and lower the odds of cesarean section without affecting offspring outcomes.
HIV-infected patients on ART had approximately 4 and 1.5 greater odds of developing diabetes mellitus and metabolic syndrome, respectively.
Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
The score can predict the effectiveness of weight-loss therapy for preventing diabetes in overweight or obese individuals.
Patients exhibiting moderate-to-severe depressive symptoms had worse adherence than nondepressed patients.
Women who took probiotics in their second trimester had lower rates of gestational diabetes.
A study of one tracking system's effect finds improvement in the management of diabetes.
Patients taking linagliptin had decreased HbA1c as well as reactive oxygen species generation and plasma lipid peroxide levels.
Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.
Diabetes incidence rates in the US and glucose intolerance worldwide increased per 1°C increase in temperature.
The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.
Individuals who consume the least amount of gluten are more likely to develop type 2 diabetes.
Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.
The position statement by the ADA incorporates updates in treatment and screening for patients with diabetic retinopathy.
Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated.